MOESM1 of PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinoma CuiXiao-bin ZhangShu-mao XuYue-xun DangHong-wei LiuChun-xia WangLiang-hai YangLan HuJian-ming LiangWei-hua JiangJin-fang LiNa LiYong ChenYun-zhao LiFeng 2016 Additional file 1: Table S1. The high sensitivity, specificity and AUC values of PFN2 in ESCC, HGIN, and LGIN.